Pliant Therapeutics, Inc.
PLRX
$1.38
-$0.09-6.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -56.17M | -49.73M | -57.76M | -55.85M | -46.96M |
| Total Depreciation and Amortization | 448.00K | 458.00K | 532.00K | 622.00K | 513.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.09M | 9.79M | 10.71M | 11.65M | 11.44M |
| Change in Net Operating Assets | -4.23M | -8.18M | 14.25M | -1.71M | 4.73M |
| Cash from Operations | -48.86M | -47.66M | -32.27M | -45.30M | -30.27M |
| Capital Expenditure | -262.00K | -209.00K | -896.00K | -1.25M | -1.49M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.38M | 39.34M | 31.86M | 11.95M | 61.04M |
| Cash from Investing | 69.11M | 39.13M | 30.96M | 10.70M | 59.55M |
| Total Debt Issued | -- | 1.00K | 0.00 | 0.00 | 19.91M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 498.00K | 101.00K | 543.00K | 684.00K | 1.88M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 498.00K | 102.00K | 543.00K | 684.00K | 21.79M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.75M | -8.43M | -770.00K | -33.91M | 51.06M |